NewsRx

Search our medical news database

Bonal International, Inc.

Bonal International, Inc. Sales Decrease 24 Percent at Nine Months

Published in Health Business Week, February 27th, 2009

Bonal International, Inc. announced FYE 2009 nine month and third quarter ending Dec. 31, 2008 unaudited results.

Bonal's nine month year-to-date revenue is down 24%. Third quarter sales are down 31% over last year to $408,917 and Bonal had a slight loss of $(14,232), which is down from a profit of $97,468 last year. Bonal's per share quarterly loss is $ (0.01) compared to $0.06 last year. Earnings for the nine months are $49,868 down from $388,192 last year. Earnings per share for the nine month period went from $0.23 last year to $0.03 per share on Dec. 31, 2008.

"Equipment sales continue to be down due to the nervousness in the industry because of...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook